Related Posts
Krsnaa Diagnostics to acquire 24% stake in start-up Apulki Healthcare
Krsnaa Diagnostics plans to acquire a 24% stake in Apulki Healthcare, securing exclusive rights to provide diagnostic services at Apulki’s oncology and cardiology hospitals. This […]
Wall Street holds near records after Fed delivers a big cut to rates
Wall Street hovers near record highs as the Federal Reserve initiates a significant interest rate cut to stave off a recession. The S&P 500 remains […]
AstraZeneca gets nod to launch cancer drug
AstraZeneca Pharma India has received approval from the Central Drugs Standard Control Organisation to import Durvalumab for sale and distribution. The drug, combined with chemotherapy, […]